Matches in Wikidata for { <http://www.wikidata.org/entity/Q91505924> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91505924 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q91505924 description "scientific article published on 01 October 2018" @default.
- Q91505924 description "wetenschappelijk artikel" @default.
- Q91505924 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q91505924 name "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 name "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 type Item @default.
- Q91505924 label "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 label "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 prefLabel "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 prefLabel "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 P1433 Q91505924-4834618F-2BFF-4449-8388-C2C8D9381229 @default.
- Q91505924 P1476 Q91505924-5AFA63AF-5AD8-4D3A-867D-CA4BB930BBF6 @default.
- Q91505924 P2093 Q91505924-746CA0E3-1698-483F-8B91-9768A2773E51 @default.
- Q91505924 P2093 Q91505924-9A95B566-3EE7-4BA4-8C9A-C4B5BF568940 @default.
- Q91505924 P2093 Q91505924-A2565F4C-90A8-4366-9312-67054E3F176E @default.
- Q91505924 P2093 Q91505924-F33D8AEF-4E45-43B8-B385-E851C6FB6E90 @default.
- Q91505924 P2860 Q91505924-0C4A52FD-13D6-47B6-83E7-FEF986053B05 @default.
- Q91505924 P304 Q91505924-F777497D-F2B8-40FB-95CA-8A00681E7DEB @default.
- Q91505924 P31 Q91505924-E540F819-787F-493C-BA1F-EB1BCD65AD71 @default.
- Q91505924 P356 Q91505924-DFB04456-BE36-4C67-9510-5DABAB6EE6A3 @default.
- Q91505924 P433 Q91505924-5B191C9A-ABB4-40F0-A20C-F056E7586A4A @default.
- Q91505924 P478 Q91505924-C1B17F1E-04B0-4436-99E2-82A2376716A1 @default.
- Q91505924 P50 Q91505924-52FF6A67-91D4-440A-908A-3F3CC3249886 @default.
- Q91505924 P50 Q91505924-7EF3E126-E5AF-40B1-B4CA-3CA39A7E2AE8 @default.
- Q91505924 P50 Q91505924-9F30C929-3A7A-488C-8359-0EE65D23A727 @default.
- Q91505924 P577 Q91505924-5004F94A-A118-4985-9D78-36AD4010A7B9 @default.
- Q91505924 P698 Q91505924-2A91E187-A683-47F3-9B3A-8254E18FF85B @default.
- Q91505924 P921 Q91505924-FCB660FA-22B0-42D1-982B-B86D4611DB25 @default.
- Q91505924 P356 ACS.MOLPHARMACEUT.8B00672 @default.
- Q91505924 P698 30226780 @default.
- Q91505924 P1433 Q3011140 @default.
- Q91505924 P1476 "Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy" @default.
- Q91505924 P2093 "Denis R Beckford Vera" @default.
- Q91505924 P2093 "J Christopher Luft" @default.
- Q91505924 P2093 "Matthew C Parrott" @default.
- Q91505924 P2093 "Russell J Mumper" @default.
- Q91505924 P2860 Q34880994 @default.
- Q91505924 P304 "5089-5102" @default.
- Q91505924 P31 Q13442814 @default.
- Q91505924 P356 "10.1021/ACS.MOLPHARMACEUT.8B00672" @default.
- Q91505924 P433 "11" @default.
- Q91505924 P478 "15" @default.
- Q91505924 P50 Q91505911 @default.
- Q91505924 P50 Q91505916 @default.
- Q91505924 P50 Q91505920 @default.
- Q91505924 P577 "2018-10-01T00:00:00Z" @default.
- Q91505924 P698 "30226780" @default.
- Q91505924 P921 Q420296 @default.